HDAC9 and neuroblastoma: The combination of m-carboxycinnamic acid bis-hydroxamide (CBHA), an HDAC inhibitor, with ATRA led to synergistic cytotoxicity against neuroblastoma cell lines in in vitro and in vivo xenograft models [67,68].